Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
|
| Series: | European Psychiatry |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933825100862/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849330257921835008 |
|---|---|
| author | Anna-Theresa Schulze Timo Schurr Fabienne Post Beatrice Frajo-Apor Covadonga M. Díaz-Caneja Walter Wolfgang Fleischhacker Michael Davidson Alex Hofer |
| author_facet | Anna-Theresa Schulze Timo Schurr Fabienne Post Beatrice Frajo-Apor Covadonga M. Díaz-Caneja Walter Wolfgang Fleischhacker Michael Davidson Alex Hofer |
| author_sort | Anna-Theresa Schulze |
| collection | DOAJ |
| format | Article |
| id | doaj-art-d23106c2bcce4ac68f6be6b5a1019c71 |
| institution | Kabale University |
| issn | 0924-9338 1778-3585 |
| language | English |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj-art-d23106c2bcce4ac68f6be6b5a1019c712025-08-20T03:46:58ZengCambridge University PressEuropean Psychiatry0924-93381778-358513010.1192/j.eurpsy.2025.10086Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST)Anna-Theresa Schulze0Timo Schurr1https://orcid.org/0000-0002-6757-7862Fabienne Post2https://orcid.org/0000-0002-3027-5473Beatrice Frajo-Apor3https://orcid.org/0000-0002-4385-1863Covadonga M. Díaz-Caneja4https://orcid.org/0000-0001-8538-3175Walter Wolfgang Fleischhacker5Michael Davidson6Alex Hofer7https://orcid.org/0000-0002-5834-4258Medical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, AustriaMedical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, AustriaMedical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, AustriaMedical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, AustriaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañlón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.Medical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, AustriaDepartment of Psychiatry, Nicosia University School of Medicine, CyprusMedical University Innsbruck, Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Division of Psychiatry I, Innsbruck, Austriahttps://www.cambridge.org/core/product/identifier/S0924933825100862/type/journal_articleearly-phase schizophreniasubjective well-beinglong-acting injectable antipsychoticspersonal recovery |
| spellingShingle | Anna-Theresa Schulze Timo Schurr Fabienne Post Beatrice Frajo-Apor Covadonga M. Díaz-Caneja Walter Wolfgang Fleischhacker Michael Davidson Alex Hofer Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) European Psychiatry early-phase schizophrenia subjective well-being long-acting injectable antipsychotics personal recovery |
| title | Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) |
| title_full | Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) |
| title_fullStr | Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) |
| title_full_unstemmed | Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) |
| title_short | Subjective well-being in early-phase schizophrenia patients using long-acting injectable vs. oral antipsychotic drugs: data from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) |
| title_sort | subjective well being in early phase schizophrenia patients using long acting injectable vs oral antipsychotic drugs data from the european long acting antipsychotics in schizophrenia trial eulast |
| topic | early-phase schizophrenia subjective well-being long-acting injectable antipsychotics personal recovery |
| url | https://www.cambridge.org/core/product/identifier/S0924933825100862/type/journal_article |
| work_keys_str_mv | AT annatheresaschulze subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast AT timoschurr subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast AT fabiennepost subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast AT beatricefrajoapor subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast AT covadongamdiazcaneja subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast AT walterwolfgangfleischhacker subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast AT michaeldavidson subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast AT alexhofer subjectivewellbeinginearlyphaseschizophreniapatientsusinglongactinginjectablevsoralantipsychoticdrugsdatafromtheeuropeanlongactingantipsychoticsinschizophreniatrialeulast |